Our ultimate goal is to develop small molecule drugs and validate their roles in viral replication inhibition. Collectively, we have the expertise in molecular and cell biology, biochemical, structural biophysical, and drug-discovery platforms. We have all the required infrastructure and resources available to realize our goals. Development of small molecule drug as antivirals include many […]
Read More